Skip to content

Addiction: all studies

Page 93 of 857: studies 921 to 930 of 8,563, newest first. Back to the addiction overview

Research

Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial.

Journal of Psychopharmacology February 1, 2021 Rebecca L Rothberg, Nour Azhari, Nancy A Haug et al. 95 citations

Sub-anesthetic ketamine administration may be helpful for substance use disorders. Converging evidence suggests that the efficacy of ketamine for certain conditions may implicate a subset of its psychoactive effects. The aim of this analysis is to evaluate whether the mystical-type effects of ketamine are critical for clinical efficacy in alcohol-dependent individuals. In this secondary...

Use and abuse of dissociative and psychedelic drugs in adolescence

Pharmacology, Biochemistry, and Behavior January 27, 2021 M.l. Shawn Bates, Keith A Trujillo 57 citations

Adolescence is a period of profound developmental changes, which run the gamut from behavioral and neural to physiological and hormonal. It is also a time at which there is an increased propensity to engage in risk-taking and impulsive behaviors like drug use. This review examines the human and preclinical literature on adolescent drug use and its consequences, with a focus on dissociatives...

Cannabis Use and Psychosis – Modern Views on the Problem. Narrative Synthesis

Medicina 2021 A. J. Kolgashkin, П. Н. Николаев, E. J. Tetenova et al. 1 citation

Cannabis continues to be the most widely used drug worldwide. Recently, there has been two trends in the field: a liberalization of cannabis-related legislation in a number of countries, as well as an increase in the content of the psychoactive component in cannabis plant – tetrahydrocannabinol. The review covers a topic that has been little studied in Russian addiction science – cannabis use...

The good, the bad, and the intoxicated

2021 Natasha Leigh Mason

Cannabis is the most commonly used illicit drug and is known to alter state of consciousness and impair neurocognitive function. However, the mechanisms underlying these effects have yet to be fully elucidated. Rodent studies suggest that 9-tetrahydrocannabinol (THC) activates dopaminergic neurons in the limbic system, subsequently enhancing dopamine, which is implicated in the rewarding...

Psychosis induced by abuse of ayahuasca: a case report.

Revista Colombiana de psiquiatria 2021 Raul Felipe Palma-álvarez, Lara Grau-López, Elena Ros-Cucurull et al. 12 citations

Ayahuasca is a psychotropic infusion prepared by boiling the bark of Amazonian plants and has many psychopharmacological effects not fully understood. Some of those effects are used as treatment for different diseases. However, the side effects of ayahuasca, including ayahuasca-induced psychosis, are an important issue. Here we report the case of a patient who had a psychotic episode after...

Author response: Self-blinding citizen science to explore psychedelic microdosing

December 11, 2020 Balázs Szigeti, Laura Kärtner, Allan Blemings et al. 1 citation

Psychedelic psychotherapy, therapy enhanced with psychedelic drugs such as LSD or psilocybin (the active ingredient of ‘magic mushrooms’), has been suggested to improve psychological well-being. For this reason, trials on psychedelic therapy for the treatment of depression, addiction and other conditions are ongoing. Recently, ‘microdosing’ – a way of administering psychedelics that involves...

Individual and combined effects of Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) on striato-cortical connectivity in the human brain

bioRxiv (Cold Spring Harbor Laboratory) November 21, 2020 Matthew B. Wall, Tom P. Freeman, Chandni Hindocha et al. 4 citations preprint

Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are two major constituents of cannabis with contrasting mechanisms of action. THC is the major psychoactive, addiction-promoting, and psychotomimetic compound, while CBD may have somewhat opposite effects. The brain effects of these drugs alone and in combination are poorly understood. In particular the striatum is implicated in the...

A review of common psychedelic drugs

Southern African Journal of Anaesthesia and Analgesia November 19, 2020 S Mayet 3 citations

Psychedelic substances have traditionally been used in medicine and religious rituals. Their use dates back thousands of years with fossil evidence as old as 10 000 years. Throughout the 1950s and 1960s psychedelics were used in clinical studies. These drugs then saw widespread use in hippie culture and were viewed as a drug of abuse with no medicinal value. Currently, psychedelics are being...

DOI: 10.36303/sajaa.2020.26.6.s3.2554 (opens in new tab) Addiction Drugs of abuse Value mathematics Psychotherapist

The loss of NMDAR-dependent LTD following cannabinoid self-administration is restored by positive allosteric modulation of CB1 receptors.

Addiction Biology November 2020 Daniela Neuhofer, Sade M Spencer, Vivian C Chioma et al.

Glutamatergic plasticity in the nucleus accumbens core (NAcore) is a key neuronal process in appetitive learning and contributes to pathologies such as drug addiction. Understanding how this plasticity factors into cannabis addiction and relapse has been hampered by the lack of a rodent model of cannabis self-administration. We used intravenous self-administration of two constituents of...

MDMA Use by Paris Medical Students: Prevalence and Characteristics

Substance Use & Misuse October 24, 2020 Balthazar Bazin, David Duroy, Michel Lejoyeux 27 citations

3,4-Methylenedioxy-N-methylamphetamine (MDMA) is increasing being used by youth in Europe and in France, but characteristics of its use are unknown. Objectives: The aim was to characterize MDMA use in a sample of French medical students. Methods: Cross-sectional study of Paris VII medical students (N = 592) with an online self-reporting questionnaire. Results: 592 students completed the online...